This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Edwards Lifesciences Corp (EW)

NYSE: Health Care

Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 2.32B 2.05B 1.90B 1.68B
Cost of Sales 557.00M 453.70M 437.30M 431.80M
Gross Operating Profit 1.77B 1.59B 1.46B 1.25B
Selling, General, and Administrative Expenses 858.00M 745.60M 705.30M 642.40M
Research & Development 346.50M 323.00M 291.30M 246.30M
Operating Income before D & A (EBITDA) 561.40M 523.20M 465.70M 358.10M
Depreciation & Amortization 68.60M 68.70M 57.30M 58.00M
Interest Income 6.40M 4.60M 4.80M 3.40M
Other Income - Net -78.40M 66.00M -17.70M 4.80M
Special Income / Charges 740.40M 0.00 0.00 -21.60M
Total Income Before Interest Expenses (EBIT) 1.16B 525.10M 395.50M 286.70M
Interest Expense 17.20M 9.80M 4.40M 3.10M
Pre-Tax Income 1.14B 515.30M 391.10M 283.60M
Income Taxes 332.90M 123.60M 97.90M 46.90M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 811.10M 391.70M 293.20M 236.70M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 811.10M 391.70M 293.20M 236.70M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 811.10M 391.70M 293.20M 236.70M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
70.70M 391.70M 293.20M 258.30M
Preferred Dividends
Net Income Available To Common 811.10M 391.70M 293.20M 236.70M
Basic EPS from Continuing Ops. 7.62 3.51 2.55 2.07
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 7.62 3.51 2.55 2.07
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 7.62 3.51 2.55 2.07
Basic Normalized Net Income/Share 0.66 3.51 2.55 2.25
EPS fr Continuing Ops. 7.48 3.44 2.48 1.98
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 7.48 3.44 2.48 1.98
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 7.48 3.44 2.48 1.98
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0.65 3.44 2.48 2.16
Dividends Paid per Share 0.00 0.00 0.00 0.00
EW News

EW Edwards Lifesciences Corp

Analysts Ratings for EW

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 9 9 9 9
Moderate Buy 0 0 0 0
Hold 7 7 7 8
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET EW ANALYST REPORT

Brokerage Partners

EW Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs